← FDA DRUG APPROVALS

FDA ANDA · ANDA209547

MALMOREDE

Sponsor: NOVAST LABS

APPLICATION
ANDA209547
TYPE
ANDA
ORIGINAL APPROVAL
2018-07-25
LATEST ACTION
2018-07-25
ROUTE
ORAL-28
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

MALMOREDEPrescription
ETHINYL ESTRADIOL 0.05MG, ETHYNODIOL DIACETATE 1MG · TABLET · ORAL-28

Approval history

2018-07-25UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →